18 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27287367	36	Evaluation of bisbenzamidines as inhibitors for matriptase-2.	University of Bonn
26421993	44	Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors.	Aurigene Discovery Technologies
24794746	168	Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy.	Aurigene Discovery Technologies
20503967	138	Factor Xa inhibitors: next-generation antithrombotic agents.	Bristol-Myers Squibb
10956211	14	GRID/CPCA: a new computational tool to design selective ligands.	Boehringer Ingelheim Pharma
9301673	234	Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine.	Klinikum Der Friedrich-Schiller-Universit£T Jena
10498204	25	Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA.	Rh£Ne-Poulenc Rorer
19805567	3	Long-lasting enfuvirtide carrier pentasaccharide conjugates with potent anti-human immunodeficiency virus type 1 activity.	Endotis Pharma
	32	Bisbenzamidine isoxazoline derivatives as factor Xa inhibitors	TBA
	13	Characterization of LY806303 as a potent and selective inhibitor of thrombin	TBA
16970403	74	Diphenyl phosphonate inhibitors for the urokinase-type plasminogen activator: optimization of the P4 position.	University of Antwerp
12036353	38	Design of selective thrombin inhibitors based on the (R)-Phe-Pro-Arg sequence.	Pfizer
10636232	58	Design, synthesis and structure-activity relationship of a series of arginine aldehyde factor Xa inhibitors. Part 1: structures based on the (D)-Arg-Gly-Arg tripeptide sequence.	Cor Therapeutics
10560742	85	3-Amidinophenylalanine-based inhibitors of urokinase.	UniversitäT Jena
9876114	111	Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.	Institut FüR Biochemie
9784099	84	Design of benzamidine-type inhibitors of factor Xa.	Institut FüR Biochemie
7473571	90	Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.	Eli Lilly